Background Budget impact analysis (BIA) is a relatively recent technique that is supposed to
be complementary to more established economic evaluations (EEs). Objective We reviewed …

This evaluation determines whether published studies to date meet the key characteristics
identified for budget impact analyses (BIA) for medicines, accomplished through a …

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and
budget impact in priority setting for global health programs | PLOS Medicine Skip to main …

Budget impact analysis (BIA) is a relatively recent method for economic evaluation (EE) in
the field of health care. It assesses the financial consequences of the introduction of a new …

A budget-impact analysis is required by many jurisdictions when adding a new drug to the
formulary. However, previous reviews have indicated that adherence to methodological …

Background Orphan drugs are indicated for the treatment of rare diseases which, in the EU,
are defined as those with a prevalence of< 5 per 10 000 inhabitants. Characteristically …

This article reviews budget-impact analyses (BIAs) published to date in peer-reviewed bio-
medical journals with reference to current best practice, and discusses where future …

Background Rotavirus infection is responsible for about 500,000 deaths annually, and the
disease burden is disproportionately borne by children in low-income countries. Recently …

Polypharmacy can result in drug–drug interactions, severe side-effects, drug–disease
interactions, inappropriate medication use in the elderly, and escalating costs. This study …

Análises de impacto orçamentário (AIO) fornecem previsões financeiras operacionais para
a implementação de uma nova tecnologia em um sistema de saúde. Até o momento, não …